To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ARL16TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
179 supporting clones for gene ARL16 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA304978 colon .b 148 to 568 1 to 418       418/418
(100 %)
9 diff
(97.9 %id)
AA306808   .b 203 to 593 1 to 389       389/389
(100 %)
3 diff
(99.3 %id)
AA329256   .b 550 to 875 1 to 329       329/329
(100 %)
5 diff
(98.5 %id)
AA338247   .f 2355 to 2526 1 to 172   tiling clone,   172/172
(100 %)
0 diff
(100 %id)
AA338381 brain .b 205 to 537 1 to 333       333/333
(100 %)
2 diff
(99.4 %id)
AA376669 small intestine .f 1204 to 1472 1 to 269       269/269
(100 %)
1 diff
(99.7 %id)
AK095847   .f 1 to 2342 2 to 2342 T40P Q41S L42S S43L A44H ... tiling clone, available from FLJ,   2342/2342
(100 %)
3 diff
(99.9 %id)
AK303526 thymus .g 11 to 899 1 to 889 exact     889/889
(100 %)
0 diff
(100 %id)
AK304718 uterus .b 162 to 1214 1 to 1053       1053/1053
(100 %)
6 diff
(99.5 %id)
AW956337   .f 1205 to 1923 1 to 718 A92C C93L A94C K95Q Q96A ...     718/724
(99 %)
20 diff
(97.3 %id)
AW960904   .b 203 to 820 1 to 618       618/619
(99 %)
2 diff
(99.7 %id)
BC105076 Brain, cerebral cortex, PCR rescued clones .b 1 to 828 1 to 828 exact tiling clone,   828/828
(100 %)
0 diff
(100 %id)
BC105078 Brain, cerebral cortex, PCR rescued clones .b 1 to 828 1 to 828 exact     828/828
(100 %)
0 diff
(100 %id)
TI_1241110707   .b 1 to 828 896 to 69 exact     828/1243
(66 %)
0 diff
(100 %id)
BE816388 breast_normal .m 262 to 523 278 to 19       260/278
(93 %)
0 diff
(100 %id)
BE938525 testis_normal .b 211 to 545 7 to 342       336/342
(98 %)
9 diff
(97.4 %id)
BF932965 nervous_tumor .l 29 to 226 203 to 8     Submitted on the opposite strand 196/205
(95 %)
1 diff
(99.6 %id)
DC300719 bladder .g 2 to 524 1 to 523 I66T     523/523
(100 %)
2 diff
(99.7 %id)
BM311411 Pancreas, Purified pancreatic islet .f 1902 to 2354 453 to 1   tiling clone,   453/453
(100 %)
0 diff
(100 %id)
BM312004 Pancreas, Purified pancreatic islet .b 210 to 729 29 to 548       520/548
(94 %)
6 diff
(99.0 %id)
BQ310184 breast .b 190 to 590 38 to 445       408/445
(91 %)
29 diff
(93.5 %id)
DA088170 cerebellum .i 1 to 536 2 to 539   tiling clone, capped   538/538
(100 %)
2 diff
(99.7 %id)
DB298194 cerebellum .i 1046 to 1588 543 to 1   tiling clone,   543/543
(100 %)
0 diff
(100 %id)
BX090742 ovarian tumor, ovary .b 314 to 1068 1 to 755       755/755
(100 %)
0 diff
(100 %id)
CB269371 adipose .b 220 to 864 1 to 643       643/643
(100 %)
4 diff
(99.4 %id)
CN359520 embryonic stem cells, DMSO-treated H9 cellline .b 189 to 796 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
CN359521 embryonic stem cells, DMSO-treated H9 cellline .b 188 to 644 1 to 457       457/457
(100 %)
5 diff
(99.0 %id)
CN359522 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 203 to 864 1 to 662       662/662
(100 %)
0 diff
(100 %id)
CN359523 embryonic stem cells, cell lines H1, H7, andH9 .b 163 to 863 1 to 701       701/701
(100 %)
4 diff
(99.5 %id)
CN359524 embryonic stem cells, cell lines H1, H7, andH9 .b 165 to 864 1 to 700       700/700
(100 %)
1 diff
(99.9 %id)
CN359525 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1 to 688 1 to 690 exact tiling clone,   690/697
(98 %)
6 diff
(99.2 %id)
CN359526 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 161 to 814 1 to 655       655/655
(100 %)
2 diff
(99.7 %id)
CN359527 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 392 to 616 1 to 225       225/225
(100 %)
0 diff
(100 %id)
CN359528 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 161 to 839 11 to 688       678/688
(98 %)
6 diff
(99.2 %id)
CN359529 embryonic stem cells, cell lines H1, H7, andH9 .g 57 to 340 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
CN414465 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 151 to 866 1 to 717       717/717
(100 %)
4 diff
(99.5 %id)
CR598237 fetal brain .g 26 to 1881 1 to 1856   tiling clone,   1856/1856
(100 %)
0 diff
(100 %id)
CR615218 B cells (Ramos cell line) Cot 25-normalized .a 141 to 1115 1 to 975   tiling clone,   975/975
(100 %)
0 diff
(100 %id)
CR616295 Placenta Cot 25-normalized .j 29 to 1554 1 to 1526   tiling clone,   1526/1526
(100 %)
0 diff
(100 %id)
AL537325 brain, fetal brain .g 968 to 1857 904 to 25   fully sequenced,   880/904
(97 %)
1 diff
(99.9 %id)
AL537326 brain, fetal brain .g 26 to 998 1 to 967   fully sequenced,   967/967
(100 %)
3 diff
(99.7 %id)
BX399418 Placenta Cot 25-normalized .j 843 to 1554 708 to 1   fully sequenced,   708/708
(100 %)
3 diff
(99.6 %id)
BX399419 Placenta Cot 25-normalized .j 29 to 873 1 to 845   fully sequenced,   845/845
(100 %)
1 diff
(99.9 %id)
BX324368 Placenta Cot 25-normalized .j 29 to 861 1 to 832       832/1125
(73 %)
7 diff
(99.4 %id)
BX360828 Placenta Cot 25-normalized .j 895 to 1556 674 to 1       674/1078
(62 %)
13 diff
(98.8 %id)
BX343337   .a 283 to 916 804 to 168   fully sequenced, Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 637/804
(79 %)
0 diff
(100 %id)
BX343338   .a 141 to 1095 1 to 946   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 946/946
(100 %)
13 diff
(98.7 %id)
AL119998 amygdala .n-u 1 to 638 1 to 638 Q62* tiling clone,   638/638
(100 %)
8 diff
(98.8 %id)
BX494547 Liver .f 17 to 368 1 to 352       352/352
(100 %)
5 diff
(98.6 %id)
BX494548 Liver .f 17 to 273 1 to 258       258/258
(100 %)
4 diff
(98.5 %id)
DW447679 Liver .f 1982 to 2176 17 to 211       195/211
(92 %)
6 diff
(97.2 %id)
EH320594   .f 1047 to 1097 1 to 51       51/51
(100 %)
0 diff
(100 %id)
EH327348   .f 1060 to 1139 1 to 80       80/80
(100 %)
0 diff
(100 %id)
DA515208 brain .f 29 to 585 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB469258 hippocampus .b 174 to 607 1 to 438       436/438
(99 %)
8 diff
(98.2 %id)
DB470387 hippocampus .b 161 to 602 1 to 442       442/442
(100 %)
10 diff
(97.8 %id)
DB538511 hippocampus .f 1905 to 2340 1 to 436     Submitted on the opposite strand 436/437
(99 %)
17 diff
(96.2 %id)
DB484644.
matches multiple genes
hypothalamus .b 162 to 609 1 to 449     also hits gene joysma 449/449
(100 %)
1 diff
(99.8 %id)
DB496458 hypothalamus .j 18 to 515 1 to 498 T8X C62X     498/498
(100 %)
2 diff
(99.6 %id)
DB567480 hypothalamus .f 1867 to 2342 1 to 476     Submitted on the opposite strand 476/478
(99 %)
5 diff
(99.0 %id)
DA551655   .f 1 to 462 2 to 463   capped   462/462
(100 %)
0 diff
(100 %id)
DB318352   .f 1794 to 2342 549 to 1       549/549
(100 %)
1 diff
(99.9 %id)
BY798481 eye .g 48 to 633 1 to 586       586/586
(100 %)
0 diff
(100 %id)
N77494 liver and spleen .b 591 to 1007 1 to 417       417/417
(100 %)
6 diff
(98.6 %id)
H94598 placenta .f 1923 to 2318 397 to 1       397/407
(97 %)
6 diff
(98.6 %id)
H95186 placenta .b 216 to 563 25 to 376       352/405
(86 %)
18 diff
(95.6 %id)
N40665 placenta .b 329 to 755 1 to 429       429/430
(99 %)
9 diff
(98.0 %id)
W25197.
matches multiple genes
lung .f 1294 to 1732 1 to 443     also hits gene RNF207 443/447
(99 %)
10 diff
(97.8 %id)
AA419014 ovarian tumor, ovary .f 2141 to 2318 178 to 1   fully sequenced,   178/178
(100 %)
0 diff
(100 %id)
AA419107 ovarian tumor, ovary .f 1961 to 2302 1 to 342   fully sequenced,   342/342
(100 %)
1 diff
(99.8 %id)
AA428991 ovarian tumor, ovary .b 800 to 1214 415 to 1   tiling clone,   415/415
(100 %)
0 diff
(100 %id)
AA429180 ovarian tumor, ovary .b 313 to 711 1 to 399       399/399
(100 %)
7 diff
(98.3 %id)
AA496042   .f 1939 to 2342 412 to 9       404/412
(98 %)
0 diff
(100 %id)
AA461610   .b 233 to 711 18 to 492       474/492
(96 %)
9 diff
(98.2 %id)
AA761454 germinal center B cell .f 1941 to 2349 424 to 16   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 409/409
(100 %)
3 diff
(99.3 %id)
AI078697 senescent fibroblast .f 1891 to 2342 464 to 12   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 453/453
(100 %)
4 diff
(99.2 %id)
AI149177 placenta .f 1988 to 2364 394 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 377/377
(100 %)
1 diff
(99.8 %id)
AI202777 anaplastic oligodendroglioma, brain .f 1864 to 2342 480 to 2       479/480
(99 %)
0 diff
(100 %id)
AI343808 2 pooled tumors (clear cell type), Kidney .f 1959 to 2342 390 to 7       384/390
(98 %)
0 diff
(100 %id)
AI361401 brain, glioblastoma (pooled) .f 1893 to 2349 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AI363336 brain, glioblastoma (pooled) .f 1931 to 2342 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AI805373 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 1911 to 2318 408 to 1       408/408
(100 %)
3 diff
(99.3 %id)
AI805556 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 1857 to 2318 462 to 1       462/462
(100 %)
3 diff
(99.4 %id)
AW131109 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 1872 to 2342 471 to 1       471/471
(100 %)
2 diff
(99.6 %id)
AW190437 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 1868 to 2343 476 to 1       476/476
(100 %)
5 diff
(99.0 %id)
BE139464 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 1885 to 2318 434 to 1       434/434
(100 %)
3 diff
(99.4 %id)
AW404068 lymph .f 1436 to 1759 8 to 331       320/331
(96 %)
6 diff
(98.2 %id)
AW405457 lymph .b 211 to 510 1 to 300       300/300
(100 %)
5 diff
(98.4 %id)
BF108837 pooled .f 1859 to 2342 491 to 8       484/491
(98 %)
0 diff
(100 %id)
BE272814 Kidney, renal cell adenocarcinoma .b 214 to 444 1 to 231       231/231
(100 %)
0 diff
(100 %id)
BF031025 hypernephroma, Kidney .b 163 to 779 1 to 614       614/614
(100 %)
8 diff
(98.7 %id)
BF030963 hypernephroma, Kidney .b 181 to 839 1 to 664       664/841
(78 %)
27 diff
(96.8 %id)
BE744359 adenocarcinoma cell line, ovary .b 213 to 1021 1 to 814       814/1209
(67 %)
33 diff
(97.3 %id)
BE746724 adenocarcinoma cell line, ovary .f 1701 to 2355 1 to 654       654/812
(80 %)
4 diff
(99.6 %id)
BF381957 brain, primitive neuroectoderm .b 161 to 786 1 to 616       618/869
(71 %)
23 diff
(97.4 %id)
BF218382 brain, glioblastoma .b 120 to 857 1 to 718       720/848
(84 %)
48 diff
(94.4 %id)
BF309809 muscle, rhabdomyosarcoma .b 168 to 845 1 to 681       681/876
(77 %)
11 diff
(98.8 %id)
BF345743 anaplastic oligodendroglioma with 1p/19qloss, brain .f 1782 to 2338 12 to 569       558/572
(97 %)
7 diff
(98.8 %id)
BF699829 brain, primitive neuroectoderm .a 75 to 750 1 to 673   tiling clone,   673/793
(84 %)
17 diff
(97.9 %id)
BF684514 leiomyosarcoma cell line, uterus .h 1 to 870 1 to 874 exact tiling clone,   874/986
(88 %)
42 diff
(95.8 %id)
BF978015 melanotic melanoma, high MDR, skin .e 1 to 723 1 to 712 T49H Q50P L51A S52L A53C ... tiling clone,   712/884
(80 %)
18 diff
(98.0 %id)
BF796736 lymph, lymphoma, cell line .b 176 to 980 1 to 804       804/850
(94 %)
17 diff
(98.0 %id)
BF791780 adrenal cortex carcinoma, cell line, adrenal gland .b 336 to 1171 1 to 846       846/1006
(84 %)
40 diff
(96.1 %id)
BF967392 brain, hypothalamus .b 156 to 906 1 to 755       755/778
(97 %)
12 diff
(98.5 %id)
BG029801 breast, mammary adenocarcinoma, cell line .b 168 to 965 1 to 794       794/1009
(78 %)
18 diff
(98.3 %id)
BF980474 duodenal adenocarcinoma, cell line, small intestine .n-u 26 to 709 1 to 692 A5C H8Q L61P Q62S E63G ... tiling clone,   692/1050
(65 %)
28 diff
(97.4 %id)
BG035440 adenocarcinoma, cell line, Liver .b 235 to 1015 1 to 784       784/800
(98 %)
21 diff
(97.4 %id)
BG105464 adrenal cortex carcinoma, cell line, adrenal gland .b 160 to 707 1 to 548       548/548
(100 %)
0 diff
(100 %id)
BG167109 hypernephroma, cell line, Kidney .b 171 to 909 1 to 742       744/880
(84 %)
49 diff
(94.5 %id)
BC063687 Prostate, adenocarcinoma. .b 199 to 1181 1 to 983   available from MGC, AAA Possibly primed on the genome, locally A rich (24/29 A in genome downstream of last aligned base) 983/983
(100 %)
1 diff
(99.9 %id)
BG255240 adenocarcinoma, cell line, Prostate .b 199 to 912 1 to 706   available from MGC,   706/807
(87 %)
22 diff
(97.3 %id)
BG396987 melanotic melanoma, skin .b 193 to 1023 1 to 822       822/870
(94 %)
23 diff
(97.4 %id)
BG400330 Kidney .b 161 to 744 1 to 601       599/677
(88 %)
28 diff
(95.9 %id)
BG430525 Kidney .b 162 to 912 1 to 750       750/751
(99 %)
25 diff
(96.7 %id)
BG427716 Kidney .m 1 to 729 1 to 730 exact tiling clone,   730/730
(100 %)
12 diff
(98.4 %id)
BG474883 melanotic melanoma, skin .l 1 to 746 1 to 756 exact tiling clone,   756/787
(96 %)
19 diff
(97.6 %id)
BG476963 melanotic melanoma, skin .b 193 to 864 1 to 673       673/673
(100 %)
2 diff
(99.8 %id)
BG478464 melanotic melanoma, skin .a 119 to 1054 1 to 935       935/946
(98 %)
34 diff
(96.5 %id)
BG482571 choriocarcinoma, placenta .a 41 to 722 25 to 706       682/706
(96 %)
12 diff
(98.4 %id)
BG496012 lung, mucoepidermoid carcinoma .b 139 to 782 1 to 660       654/973
(67 %)
20 diff
(98.0 %id)
BG576428 breast, mammary adenocarcinoma, cell line .f 1775 to 2332 19 to 581       563/582
(96 %)
6 diff
(99.0 %id)
BC029633 Skin, squamous cell carcinoma .f 1105 to 2349 1 to 1245 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 1245/1245
(100 %)
45 diff
(96.4 %id)
BG677259 skin, squamous cell carcinoma .f 1105 to 1973 1 to 879 I103N S104Q A105R R106P E107* available from MGC,   879/891
(98 %)
30 diff
(96.7 %id)
BG742222 skin .b 176 to 988 1 to 815       815/815
(100 %)
9 diff
(98.9 %id)
BI092430 cervix .b 182 to 1041 1 to 864       864/870
(99 %)
7 diff
(99.2 %id)
BI116339 lung, small cell carcinoma .b 175 to 931 1 to 758       758/759
(99 %)
10 diff
(98.7 %id)
BC042380 Brain, hypothalamus .b 163 to 1226 1 to 1064   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (24/29 A in genome downstream of last aligned base) 1064/1064
(100 %)
3 diff
(99.8 %id)
BI596413 brain, hypothalamus .b 156 to 651 1 to 496   available from MGC,   496/500
(99 %)
6 diff
(98.8 %id)
BI554269 anaplastic oligodendroglioma with 1p/19qloss, brain .b 189 to 865 1 to 689       689/1236
(55 %)
12 diff
(99.1 %id)
BI860368 breast, mammary adenocarcinoma, cell line .b 135 to 897 15 to 783       769/783
(98 %)
19 diff
(97.6 %id)
BM563228 astrocytoma grade IV, cell line, brain .b 152 to 965 18 to 833       816/985
(82 %)
13 diff
(98.7 %id)
BM470398 eye, retinoblastoma .d 1 to 740 1 to 740 exact tiling clone, AAA   740/740
(100 %)
4 diff
(99.5 %id)
CK821760 Pancreas, Purified pancreatic islet .b 241 to 824 1 to 584     Submitted on the opposite strand 584/584
(100 %)
0 diff
(100 %id)
CK821761 Pancreas, Purified pancreatic islet .f 1770 to 2355 594 to 9     Submitted on the opposite strand 586/594
(98 %)
0 diff
(100 %id)
CA335952 anterior rhombomeres 1-4 (4 pooled) .b 169 to 759 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BM923769 pooled colon, kidney, stomach .f 70 to 952 1 to 888       888/990
(89 %)
9 diff
(99.1 %id)
BM925019 pooled lung and spleen .b 177 to 1014 8 to 850       843/1054
(79 %)
28 diff
(97.4 %id)
BM925175 pooled lung and spleen .b 177 to 1110 8 to 945       938/1031
(90 %)
31 diff
(97.0 %id)
BM926628 pooled lung and spleen .j 28 to 1015 14 to 1002       989/1098
(90 %)
13 diff
(98.9 %id)
BQ029151 lung, Metastatic Chondrosarcoma .f 1902 to 2349 464 to 17   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 448/448
(100 %)
3 diff
(99.4 %id)
BU163942 large cell carcinoma, lung .b 179 to 915 1 to 739       739/934
(79 %)
11 diff
(98.9 %id)
BQ614380 insulinoma, Pancreas .f 1813 to 2286 474 to 1       474/474
(100 %)
2 diff
(99.6 %id)
BQ549808 insulinoma, Pancreas .i 546 to 979 128 to 561   tiling clone, Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 566/561
(100 %)
59 diff
(89.5 %id)
BQ613932 insulinoma, Pancreas .i 1056 to 1588 549 to 17   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 533/533
(100 %)
2 diff
(99.7 %id)
BQ786841 Pancreas, Purified pancreatic islet .f 1836 to 2355 520 to 1   fully sequenced,   520/520
(100 %)
5 diff
(99.1 %id)
BQ787111 Pancreas, Purified pancreatic islet .f 1510 to 1866 9 to 365   fully sequenced,   357/365
(97 %)
10 diff
(97.3 %id)
BQ223687 melanotic melanoma, skin .b 210 to 1057 1 to 858       858/894
(95 %)
28 diff
(96.9 %id)
BU159836 eye, retinoblastoma .b 152 to 1025 16 to 897       882/899
(98 %)
21 diff
(97.7 %id)
BU160614 melanotic melanoma, skin .b 198 to 982 1 to 786       786/893
(88 %)
31 diff
(96.6 %id)
BU189027 melanotic melanoma, skin .b 178 to 1025 1 to 850       850/850
(100 %)
5 diff
(99.5 %id)
BQ668684 epidermoid carcinoma, cell line, salivary gland .b 137 to 970 1 to 848       848/929
(91 %)
24 diff
(97.5 %id)
BU501448 eye, normal pigmented retinal epithelium .b 197 to 848 1 to 659       659/1021
(64 %)
16 diff
(98.5 %id)
BU567019 mixed (pool of 40 RNAs) .f 1954 to 2341 1 to 388   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 388/388
(100 %)
2 diff
(99.5 %id)
DR760347 embryonic stem .f 64 to 855 1 to 792   tiling clone,   792/792
(100 %)
1 diff
(99.9 %id)
CB995068 placenta, pre-eclamptic placenta .a 1 to 782 24 to 809 S30T R179H tiling clone,   786/814
(96 %)
19 diff
(97.7 %id)
CD102307 Pooled-Skin .b 160 to 819 36 to 702       667/757
(88 %)
17 diff
(97.8 %id)
CF126971 Chondrosarcoma Lung Metastasis cell lines, lung .b 181 to 883 1 to 701       701/701
(100 %)
4 diff
(99.5 %id)
DA611148   .k 1 to 551 2 to 552 H25R tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
TI_44384973   .b 187 to 827 47 to 692       646/1238
(52 %)
6 diff
(99.6 %id)
TI_45209271   .b 164 to 651 94 to 581       488/585
(83 %)
7 diff
(98.9 %id)
TI_57187924   .b 135 to 897 104 to 872       769/783
(98 %)
19 diff
(97.6 %id)
DC361980 Kidney .g 1 to 565 1 to 565 exact tiling clone,   565/565
(100 %)
1 diff
(99.9 %id)
CB111460 Liver .b 167 to 700 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
CB119737 Liver .b 328 to 825 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BP429275   .b 378 to 702 1 to 325       325/325
(100 %)
4 diff
(98.8 %id)
NM_001040025.1   .b 1 to 1207 1 to 1207 exact RefSeq,   1207/1207
(100 %)
0 diff
(100 %id)
BM837665 Ascites, stomach .j 9 to 660 1 to 652 exact     652/652
(100 %)
2 diff
(99.7 %id)
BM761972 myeloma .a 112 to 733 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BM782864 myeloma .b 296 to 396 1 to 101       101/101
(100 %)
0 diff
(100 %id)
BM821150 stomach .b 170 to 550 1 to 381       381/381
(100 %)
0 diff
(100 %id)
DB010739 colon, tumor tissue .j 1 to 521 2 to 521 G64A I66S W67G S68P S69V ... tiling clone, capped   520/520
(100 %)
1 diff
(99.9 %id)
DB014955 esophageal, tumor tissue .f 26 to 497 15 to 487   capped   473/486
(97 %)
8 diff
(98.4 %id)
DC409805 thymus .g 11 to 619 1 to 610 exact     610/610
(100 %)
1 diff
(99.9 %id)
DC424715 thyroid gland .g 5 to 760 1 to 754 exact     754/758
(99 %)
11 diff
(98.6 %id)
DC427478 thyroid gland .g 1426 to 1916 494 to 1   tiling clone,   494/497
(99 %)
17 diff
(96.6 %id)
TI_149277995   .b 494 to 1205 795 to 85   AAA Possibly primed on the genome, locally A rich (24/29 A in genome downstream of last aligned base) 711/712
(99 %)
4 diff
(99.5 %id)
TI_154140898   .f 1436 to 1996 81 to 642 A112X G113R     562/566
(99 %)
13 diff
(97.8 %id)
TI_154142683   .b 216 to 824 79 to 687       609/621
(98 %)
45 diff
(92.8 %id)
TI_154190056   .b 181 to 1217 51 to 1078       1028/1029
(99 %)
37 diff
(96.5 %id)
BU678136 lung .f 1650 to 2333 693 to 11   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 683/691
(98 %)
4 diff
(99.5 %id)
BM688305 eye, human retina .m 40 to 579 19 to 559       541/559
(96 %)
7 diff
(98.8 %id)
BM671215 eye, optic nerve .f 1689 to 2341 671 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 653/669
(97 %)
1 diff
(99.9 %id)
TI_151771554   .f 1689 to 2248 105 to 666       562/909
(61 %)
12 diff
(98.7 %id)
DC420635 uterus .g 2 to 563 1 to 562 exact     562/562
(100 %)
0 diff
(100 %id)
DC422529 uterus .b 162 to 645 1 to 484       484/484
(100 %)
0 diff
(100 %id)
DA064242 cerebellum .b 241 to 824 1 to 584   capped Suspected internal deletion, suspected internal deletion, this clone was ignored 584/584
(100 %)
0 diff
(100 %id)
AV685754 hepatocellular carcinoma .b 241 to 824 1 to 584     Suspected internal deletion, suspected internal deletion, this clone was ignored 584/584
(100 %)
0 diff
(100 %id)
AV658134 corresponding non cancerous liver tissue .f 1770 to 2355 594 to 9     Submitted on the opposite strand, submitted on the opposite strand, submitted on the opposite strand 586/594
(98 %)
0 diff
(100 %id)
DB486549.
matches multiple genes
hypothalamus .f 1770 to 2355 594 to 9     This clone was ignored, also hits gene joysma 586/594
(98 %)
0 diff
(100 %id)
DB486549.
matches multiple genes
hypothalamus .b 169 to 759 1 to 591     This clone was ignored, also hits gene joysma 591/591
(100 %)
0 diff
(100 %id)
DB555553.
matches multiple genes
hypothalamus .f 70 to 952 1 to 888     This clone was ignored, also hits gene joysma 888/990
(89 %)
9 diff
(99.1 %id)
DB555553.
matches multiple genes
hypothalamus .b 177 to 1014 8 to 850     This clone was ignored, also hits gene joysma 843/1054
(79 %)
28 diff
(97.4 %id)
BU194625 melanotic melanoma, skin .b 177 to 1110 8 to 945     Suspected internal deletion, this clone was ignored 938/1031
(90 %)
31 diff
(97.0 %id)
BM926628 pooled lung and spleen .j 28 to 1015 14 to 1002       989/1098
(90 %)
13 diff
(98.9 %id)
BQ029151 lung, Metastatic Chondrosarcoma .f 1902 to 2349 464 to 17   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 448/448
(100 %)
3 diff
(99.4 %id)
BQ029151 lung, Metastatic Chondrosarcoma .f 1902 to 2349 464 to 17   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 448/448
(100 %)
3 diff
(99.4 %id)
BU163942 large cell carcinoma, lung .b 179 to 915 1 to 739       739/934
(79 %)
11 diff
(98.9 %id)
BU163942 large cell carcinoma, lung .b 179 to 915 1 to 739       739/934
(79 %)
11 diff
(98.9 %id)
BQ614380 insulinoma, Pancreas .f 1813 to 2286 474 to 1       474/474
(100 %)
2 diff
(99.6 %id)
BQ614380 insulinoma, Pancreas .f 1813 to 2286 474 to 1       474/474
(100 %)
2 diff
(99.6 %id)
BQ549808 insulinoma, Pancreas .i 546 to 979 128 to 561   tiling clone, Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 566/561
(100 %)
59 diff
(89.5 %id)
BQ549808 insulinoma, Pancreas .i 546 to 979 128 to 561   tiling clone, Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 566/561
(100 %)
59 diff
(89.5 %id)
BQ613932 insulinoma, Pancreas .i 1056 to 1588 549 to 17   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 533/533
(100 %)
2 diff
(99.7 %id)
BQ613932 insulinoma, Pancreas .i 1056 to 1588 549 to 17   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 533/533
(100 %)
2 diff
(99.7 %id)
BQ786841 Pancreas, Purified pancreatic islet .f 1836 to 2355 520 to 1   fully sequenced,   520/520
(100 %)
5 diff
(99.1 %id)
BQ786841 Pancreas, Purified pancreatic islet .f 1836 to 2355 520 to 1   fully sequenced,   520/520
(100 %)
5 diff
(99.1 %id)
BQ787111 Pancreas, Purified pancreatic islet .f 1510 to 1866 9 to 365   fully sequenced,   357/365
(97 %)
10 diff
(97.3 %id)
BQ787111 Pancreas, Purified pancreatic islet .f 1510 to 1866 9 to 365   fully sequenced,   357/365
(97 %)
10 diff
(97.3 %id)
BQ223687 melanotic melanoma, skin .b 210 to 1057 1 to 858       858/894
(95 %)
28 diff
(96.9 %id)
BQ223687 melanotic melanoma, skin .b 210 to 1057 1 to 858       858/894
(95 %)
28 diff
(96.9 %id)
BU159836 eye, retinoblastoma .b 152 to 1025 16 to 897       882/899
(98 %)
21 diff
(97.7 %id)
BU159836 eye, retinoblastoma .b 152 to 1025 16 to 897       882/899
(98 %)
21 diff
(97.7 %id)
BU160614 melanotic melanoma, skin .b 198 to 982 1 to 786       786/893
(88 %)
31 diff
(96.6 %id)
BU160614 melanotic melanoma, skin .b 198 to 982 1 to 786       786/893
(88 %)
31 diff
(96.6 %id)
BU189027 melanotic melanoma, skin .b 178 to 1025 1 to 850       850/850
(100 %)
5 diff
(99.5 %id)
BU189027 melanotic melanoma, skin .b 178 to 1025 1 to 850       850/850
(100 %)
5 diff
(99.5 %id)
BQ668684 epidermoid carcinoma, cell line, salivary gland .b 137 to 970 1 to 848       848/929
(91 %)
24 diff
(97.5 %id)
BQ668684 epidermoid carcinoma, cell line, salivary gland .b 137 to 970 1 to 848       848/929
(91 %)
24 diff
(97.5 %id)
BU501448 eye, normal pigmented retinal epithelium .b 197 to 848 1 to 659       659/1021
(64 %)
16 diff
(98.5 %id)
BU501448 eye, normal pigmented retinal epithelium .b 197 to 848 1 to 659       659/1021
(64 %)
16 diff
(98.5 %id)
BU567019 mixed (pool of 40 RNAs) .f 1954 to 2341 1 to 388   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 388/388
(100 %)
2 diff
(99.5 %id)
DR760347 embryonic stem .f 64 to 855 1 to 792   tiling clone,   792/792
(100 %)
1 diff
(99.9 %id)
CB995068 placenta, pre-eclamptic placenta .a 1 to 782 24 to 809 S30T R179H tiling clone,   786/814
(96 %)
19 diff
(97.7 %id)
CB995068 placenta, pre-eclamptic placenta .a 1 to 782 24 to 809 S30T R179H tiling clone,   786/814
(96 %)
19 diff
(97.7 %id)
CD102307 Pooled-Skin .b 160 to 819 36 to 702       667/757
(88 %)
17 diff
(97.8 %id)
CF126971 Chondrosarcoma Lung Metastasis cell lines, lung .b 181 to 883 1 to 701       701/701
(100 %)
4 diff
(99.5 %id)
CF126971 Chondrosarcoma Lung Metastasis cell lines, lung .b 181 to 883 1 to 701       701/701
(100 %)
4 diff
(99.5 %id)
DA611148   .k 1 to 551 2 to 552 H25R tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
TI_44384973   .b 187 to 827 47 to 692       646/1238
(52 %)
6 diff
(99.6 %id)
TI_45209271   .b 164 to 651 94 to 581       488/585
(83 %)
7 diff
(98.9 %id)
TI_57187924   .b 135 to 897 104 to 872       769/783
(98 %)
19 diff
(97.6 %id)
DC361980 Kidney .g 1 to 565 1 to 565 exact tiling clone,   565/565
(100 %)
1 diff
(99.9 %id)
CB111460 Liver .b 167 to 700 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
CB119737 Liver .b 328 to 825 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BP429275   .b 378 to 702 1 to 325       325/325
(100 %)
4 diff
(98.8 %id)
NM_001040025.1   .b 1 to 1207 1 to 1207 exact RefSeq,   1207/1207
(100 %)
0 diff
(100 %id)
BM837665 Ascites, stomach .j 9 to 660 1 to 652 exact     652/652
(100 %)
2 diff
(99.7 %id)
BM837665 Ascites, stomach .j 9 to 660 1 to 652 exact     652/652
(100 %)
2 diff
(99.7 %id)
BM761972 myeloma .a 112 to 733 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BM782864 myeloma .b 296 to 396 1 to 101       101/101
(100 %)
0 diff
(100 %id)
BM821150 stomach .b 170 to 550 1 to 381       381/381
(100 %)
0 diff
(100 %id)
DB010739 colon, tumor tissue .j 1 to 521 2 to 521 G64A I66S W67G S68P S69V ... tiling clone, capped   520/520
(100 %)
1 diff
(99.9 %id)
DB014955 esophageal, tumor tissue .f 26 to 497 15 to 487   capped   473/486
(97 %)
8 diff
(98.4 %id)
DC409805 thymus .g 11 to 619 1 to 610 exact     610/610
(100 %)
1 diff
(99.9 %id)
DC424715 thyroid gland .g 5 to 760 1 to 754 exact     754/758
(99 %)
11 diff
(98.6 %id)
DC427478 thyroid gland .g 1426 to 1916 494 to 1   tiling clone,   494/497
(99 %)
17 diff
(96.6 %id)
TI_149277995   .b 494 to 1205 795 to 85   AAA Possibly primed on the genome, locally A rich (24/29 A in genome downstream of last aligned base) 711/712
(99 %)
4 diff
(99.5 %id)
TI_154140898   .f 1436 to 1996 81 to 642 A112X G113R     562/566
(99 %)
13 diff
(97.8 %id)
TI_154142683   .b 216 to 824 79 to 687       609/621
(98 %)
45 diff
(92.8 %id)
TI_154190056   .b 181 to 1217 51 to 1078       1028/1029
(99 %)
37 diff
(96.5 %id)
BU678136 lung .f 1650 to 2333 693 to 11   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 683/691
(98 %)
4 diff
(99.5 %id)
BM688305 eye, human retina .m 40 to 579 19 to 559       541/559
(96 %)
7 diff
(98.8 %id)
BM688305 eye, human retina .m 40 to 579 19 to 559       541/559
(96 %)
7 diff
(98.8 %id)
BM671215 eye, optic nerve .f 1689 to 2341 671 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 653/669
(97 %)
1 diff
(99.9 %id)
BM671215 eye, optic nerve .f 1689 to 2341 671 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 653/669
(97 %)
1 diff
(99.9 %id)
TI_151771554   .f 1689 to 2248 105 to 666       562/909
(61 %)
12 diff
(98.7 %id)
DC420635 uterus .g 2 to 563 1 to 562 exact     562/562
(100 %)
0 diff
(100 %id)
DC422529 uterus .b 162 to 645 1 to 484       484/484
(100 %)
0 diff
(100 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C